Booth 5589

At SupplySide Global, Logical Square will discuss recent clinical findings on CaFi, a Cassia fistula extract, validating its role in supporting gut health, potentially more efficiently than Senna (Cassia angustifolia).

Late last year, the company presented the first clinical study on CaFi, showing benefits and safety in healthy adults. This year, two studies will be revealed, highlighting benefits in pediatric and geriatric populations.

The company will also unveil its CARSE (competent and reliable scientific evidence) report providing a review of studies backing the ingredient.

CaFi is highly palatable and stable across multiple dosage formats, from gummies and chewables to capsules, tablets, liquids, and powders.

Visitors at Logical Square’s booth can speak to the company’s technical experts to learn more about:

• Scientific data on CaFi from three clinical trials;
• The CARSE report on the ingredient’s safety and efficacy
• Finished product samples including gummies, chewables, ready-to-drink liquids, and capsules/tablets
• Formulation and product development

“It’s time for a change,” said Harris Sheikh, co-founder. “For years, senna has been the go-to for gut health, but we’re introducing a new gold standard – delivering clinically validated gut health support, at a competitive price, with unmatched safety and reliability for the whole family.”